Skip To Main Content
Ningxia Wu on Muck Rack

Ningxia Wu

As seen in: MDPI, BMC Cancer, Aging
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Ningxia Wu’s profile

Articles by Ningxia Wu

IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination - BMC Cancer

|
By Ningxia Wu, Yuting Ruan, Wen Ge, Pei Ma, Tongpeng Xu, Yongqian Shu, Yingwei Wang, Wen Qiu, Chenhui Zhao, Shuai Ying
| BMC Cancer Verified
Anti-IL-17RA (Cat. no. ab180904), anti-ubiquitin-K63 (Cat. no. ab179434) and anti-ubiquitin-K48 (Cat. no. ab140601) were obtained from Abcam (Cambridge, UK). Anti-MEF2C (Cat. no. 10056-1-AP), anti-TRIM31 (Cat. no. A10639), anti-PD-L1 (Cat. no. A1645), anti-HA (Cat. no. 81290-1-RR) and anti-Flag (Cat. no. 80010-1-RR) were obtained from Proteintech Biotech or ABclonal Biotech (Wuhan, China). Anti-rabbit (Cat. no. A7016) and anti-mouse (Cat. no.
Open in Who Shared Issue with article?

Causal effects for neurodegenerative diseases on the risk of myocardial infarction: a two-sample Mendelian randomization study

|
By Jianing Chi, Jiaman Hu, Ningxia Wu, Hua Cai
| Aging Verified
Research Paper Volume 16, Issue 11 pp 9944—9958 1 Department of Geriatric Cardiology, General Hospital of Southern Theater Command, Guangzhou, China 2 Branch of National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Guangzhou, China 3 Guangzhou Key Laboratory of Cardiac Rehabilitation, Guangzhou, China 4 The First School of Clinical Medicine, Southern Medical University, Guangzhou, China 5 School of Public Health, Guangdong Pharmaceutical University,...
Open in Who Shared Issue with article?

Causal effects for neurodegenerative diseases on the risk of myocardial infarction: a two-sample Mendelian randomization study

|
By Jiaman Hu, Ningxia Wu, Hua Cai, Jianing Chi
| Aging Verified
Research Paper Volume 16, Issue 11 pp 9944—9958 1 Department of Geriatric Cardiology, General Hospital of Southern Theater Command, Guangzhou, China 2 Branch of National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Guangzhou, China 3 Guangzhou Key Laboratory of Cardiac Rehabilitation, Guangzhou, China 4 The First School of Clinical Medicine, Southern Medical University, Guangzhou, China 5 School of Public Health, Guangdong Pharmaceutical University,...
Open in Who Shared View Duplicates (11) Issue with article?

Chimeric Peptide Engineered Nanomedicine for Synergistic Suppression of Tumor Growth and Therapy-Induced Hyperlipidemia by mTOR and PCSK9 Inhibition

|
By Hua Cai, Rongrong Zheng, Jiaman Hu, Ningxia Wu
| MDPI
1. Introduction Tumors and cardiovascular diseases have the highest morbidity and mortality rates in the world. Both of them have some common risk factors such as hyperlipidemia and diabetes, resulting in a large number of patients with malignancy accompanied by cardiovascular disease [1,2].
Open in Who Shared Issue with article?
Show More